Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. comparison with restriction fragment length polymorphism and conventional cytogenetic analyses
- 10 April 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 61 (2) , 185-191
- https://doi.org/10.1002/ijc.2910610208
Abstract
Chromosome 1 abnormalities are indicators of prognosis in neuroblastoma (NB) but are not yet routinely exploited because conventional methods are technically demanding. We evaluated the pertinence of interphase cytogenetics fluorescence in situ hybridization (FISH) for the analysis of chromosome 1 in NB, compared with conventional methods. Deletion of 1p was detected in 8 of 9 cell lines analyzed by both FISH and restriction fragment length polymorphism (RFLP), but was evidenced in only 2 cases by conventional cytogenetics, painting analysis being required to reveal the other cases. The chromosome 1 number evaluated by FISH reflected the total chromosome modal number obtained by cytogenetics. Twenty‐eight specimens obtained from ultrasound‐guided punctures, surgical biopsies of the primary tumor and bone‐marrow aspirates were studied by FISH on frozen cytocentrifuged smears; 12 had a chromosome 1 trisomy and 16 a disomy. Requirements for a reliable control analysis of 1p deletion by RFLP were met in only 23 cases. The retention of 2 alleles was observed in 15 cases and 1p deletion in 7, by both techniques. In one case, an interstitial deletion of 1p was evidenced only by RFLP, and one of 5 cases analyzed only by FISH had a 1p deletion. Although FISH might be improved by using additional probes, it presents major advantages for routine exploitation. Determining 1p deletion in individual cells makes it possible to analyze small and heterogeneous tumoral specimens; the technique requires only a few hours and can easily be standardized in non‐specialized laboratories. The number of chromosome 1 homologues per cell might serve as a rapid screening for ploidy. © 1995 Wiley‐Liss, Inc.Keywords
This publication has 23 references indexed in Scilit:
- Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smearsBritish Journal of Cancer, 1994
- CD44 -- A New Prognostic Marker for NeuroblastomaNew England Journal of Medicine, 1993
- Prognostic Factors in Metastatic NeuroblastomaJournal of Pediatric Hematology/Oncology, 1992
- Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantationBritish Journal of Cancer, 1989
- Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.Proceedings of the National Academy of Sciences, 1989
- Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastomaBritish Journal of Cancer, 1988
- Abstracts of workshop presentations (Part 6 of 16)Cytogenetic and Genome Research, 1987
- Biologic Differences between Neuroblastoma Stages IV-S and IVNew England Journal of Medicine, 1981
- Cloning of human satellite III DNA: different components are on different chromosomesNucleic Acids Research, 1979
- A proposed staging for children with neuroblastoma.Children's cancer study group ACancer, 1971